| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $293.0M | +6.8% |
| Cost of Revenue | $76.3M | -3.8% |
| Gross Profit | $216.7M | +11.0% |
| R&D Expense | $8.8M | +12.9% |
| SG&A Expense | $71.1M | +14.6% |
| Operating Income | $22.2M | +22.9% |
| Pre-tax Income | $23.5M | +48.9% |
| Income Tax | $6.5M | +151.2% |
| Net Income | $17.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.4M | +54.6% |
| Accounts Receivable | $44.9M | +4.1% |
| Inventory | $18.7M | -17.1% |
| Current Assets | $177.6M | +22.2% |
| Total Assets | $297.9M | +5.9% |
| Current Liabilities | $40.7M | -0.9% |
| Total Liabilities | $81.3M | -7.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $40.7M | +13.4% |
| Capital Expenditures | $2.4M | +2.9% |
| Investing Cash Flow | -$2.5M | -0.6% |
| Financing Cash Flow | -$4.8M | -184.2% |
| Free Cash Flow | $38.3M | +14.1% |
| -40.5% |
| EPS (Basic) | $0.71 | -42.7% |
| EPS (Diluted) | $0.70 | -43.1% |
| Stockholders' Equity |
| $216.6M |
| +11.9% |